Europe Throat Cancer Diagnostics Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 429.94 Million |
 Market Size (Forecast Year) |
USD 721.95 Million |
 CAGR |
% |
| Major Markets Players |
Europe Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others), Distribution Channel (Direct Tender and Retail Sales) - Industry Trends and Forecast to 2030.
Europe Throat Cancer Diagnostics Market
Increasing awareness about throat cancer has enhanced the market demand. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period.
Europe throat cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.7% in the forecast period of 2023 to 2030 and is expected to reach USD 721.95 million by 2030 from USD 429.94 million in 2022.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customisable to 2020-2015) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others), Distribution Channel (Direct Tender and Retail Sales) |
|
Countries Covered |
Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe |
|
Market Players Covered |
F. Hoffmann-La Roche Ltd., FUJIFILM Corporation, Thermo Fisher Scientific Inc., CANON MEDICAL SYSTEMS CORPORATION, Koninklijke Philips N.V., Merck KGaA, BD, General Electric Company, Illumina, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Abbott, QIAGEN, Siemens Healthcare GmbH, Myriad Genetics Inc., Quest Diagnostics Incorporated, Hologic, FONAR Corp., Medonica Co. LTD, SternMed GmbH, MinFound Medical Systems Co., Ltd, and PlexBio among others |
Market Definition
Throat cancer is a type of cancer that forms in tissues of the pharynx (the hollow tube inside the neck that starts behind the nose and ends at the top of the windpipe and esophagus). Throat cancer includes cancer of the nasopharynx (the upper part of the throat behind the nose), the oropharynx (the middle part of the pharynx), and the hypopharynx (the bottom part of the pharynx). Cancer of the larynx (voice box) may also be included as a type of throat cancer. Most throat cancers are squamous cell carcinomas (cancer that begins in thin, flat cells that look like fish scales), also called pharyngeal cancer.
Europe Throat Cancer Diagnostics Market Dynamics
Drivers
- Growing prevalence of throat cancer
Throat cancer is the second most common type of leukemia diagnosed in adults and children, but most cases occur in adults. Although it can be diagnosed at any age, it is uncommon before age 45. The average age of diagnosis is age 68. The rising use of cigarettes and other tobacco substitutes may be partially responsible for the rise in the prevalence of throat cancer.
People affected with throat cancer can see the symptoms such as a cough, changes in their voice, such as hoarseness or not speaking clearly, difficulty swallowing, ear pain, a lump or sore that doesn't heal, a sore throat, and weight loss among others.
- Novel technological advancements in throat cancer diagnostics
Radiotherapy has an integral role in the treatment of throat cancer. Although radiotherapy has the potential to cure patients with advanced diseases, it also carries the potential for significant long-term morbidity. New technologies in the setting of head and neck radiotherapy are emerging, which have the potential to increase the cure rate and decrease toxicity. These new technologies include improved radiotherapy treatment design (intensity-modulated radiation therapy) and improved planning and implementation (image-guided radiation therapy).
Restraints
- Late diagnosis and poor prognosis of throat cancer
Cancer is the leading cause of death worldwide. By 2030, it is anticipated that there will be 13.1 million more cancer-related deaths per year. However, if they are identified early on and given the right care, some cancers can be cured. The diagnostic process may experience delays in cancer diagnosis. When patients overlook or fail to respond to potentially cancerous signs, the late patient diagnosis will lead to the growth of cancerous tissue, worsening the cancer condition. The main cause of delayed presentation is a lack of public knowledge of early cancer signs, especially if such symptoms are unusual.
Thus, the late diagnosis often results from these factors, which result in poor prognosis. Thus, these are expected to restrain the growth of the Europe throat cancer diagnostics market.
High cost for the installation of diagnostic devices
Cancer diagnostics have become increasingly expensive due to the growing number of throat cancer patients and the rising prices of medical devices. The modern technological devices used in cancer diagnosis also play a significant role in the high prices of cancer diagnostics, providing a definitive diagnosis for cancer in thyroid nodules with high accuracy. Therefore, the high cost of diagnostics procedures for throat cancers is hampering the market's growth.
The diagnostic products or devices which are used in the detection of cancer are becoming advanced. However, the procedure for cancer diagnostics is also costly, which hampers the growth of the throat cancer diagnostics market because the devices used in the process of cancer diagnosis are getting more expensive for the early detection of cancerous tissue, which results in to increase in the cost of diagnostics procedure.
Opportunities
- Rise in healthcare expenditure for cancer diagnosis and treatment
Across the globe, research and development activities are escalating owing to the public health expenditure with economic performances. Rising healthcare expenditure could result in better provision of research and development opportunities. It is anticipated to increase the demand for throat diagnostics. Increasing the healthcare expenditure for cancer treatment also helps the patient take hassle-free advanced diagnostics and treatment for fast recovery. The spending on healthcare is made up of the combination of out-of-pocket payments (people paying for their care), government expenditure, and various sources such as different healthcare schemes published by the government in different regions. It also includes health insurance and activities by non-governmental organizations. This increasing healthcare expenditure for cancer treatment is an opportunity for the market's demand.
- Government initiatives toward cancer diagnostics
The government plays a major role while taking the initiative for cancer diseases because cancer is a leading disease worldwide. Throat cancer has increased very rapidly in individuals in past decades. Throat cancer is the most prevalent cancer, with estimated 410,376 people new cases in 2022, according to cancer.gov.
There are several initiatives taken by the government that helps boost the market's demand, and these initiatives will increase awareness among people regarding their health and take early diagnosis for better cure and precaution. Growing healthcare expenditure is also beneficial for further economic growth and healthcare sector growth, and it is primarily fruitful as it significantly affects the development of better and advanced therapeutic options with various diagnostics products.
Challenges
- Increased cost, safety, and convenience issues
Throat cancer is fatal, and the diagnosis process of this type of cancer also has safety issues. It is also not cost-effective. One of the most costly medical disorders to treat globally is cancer. Cancer patients may be hospitalized and receive a variety of therapies, such as surgery, radiation therapy, and systemic therapy. Health insurance premiums for cancer patients are now more expensive than in the past. In addition, their co-payment, deductible, and coinsurance costs are rising.
Rising helium shortage and rising risk of excessive radiation exposure are projected to restrict the use of CT scanners, threatening the possibilities of rising capital investments and low benefit-cost ratio for biomarkers. Many hospitals in developing countries cannot invest in diagnostic imaging equipment, which has led to increased use of reconstructed diagnostic imaging due to high expenditures and financial restrictions.
Recent Developments
- In August 2022, F. Hoffmann-La Roche Ltd, announced the launch of the Digital LightCycler System, Roche's first digital polymerase chain reaction (PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods. This has helped the company to increase its Europe presence in the market
- In March 2021, Hologic, Inc. announced that the company had acquired Diagenode, a privately held Globalan developer and manufacturer of molecular diagnostic assays and epigenetics products. This further strengthens the molecular diagnostics business in the Europe market
Europe Throat Cancer Diagnostics Market Scope
The Europe throat cancer diagnostics market is segmented into product type, test type, cancer type, stages, age group, end user, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product Type
- Instruments
- Consumables & accessories
On the basis of product type, the Europe throat cancer diagnostics market is segmented into instruments and consumables & accessories.
Test Type
- Imaging Test
- Blood Test
- Biopsy
- Others
On the basis of test type, the Europe throat cancer diagnostics market is segmented into imaging test, blood test, biopsy, and others.
Cancer Type
- Pharyngeal cancer
- Laryngeal cancer
On the basis of cancer type, the Europe throat cancer diagnostics market is segmented into pharyngeal cancer and laryngeal cancer.
Stages
- Stage 0
- Stage I
- Stage II
- Stage III
- Stage IV
On the basis of stages, the Europe throat cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV.
Age Group
- 30-65
- 65 and above
- 21-29
- Below 21
On the basis of age group, the Europe throat cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, and below 21.
End User
- Hospitals
- Associated labs
- Independent diagnostic laboratories
- Diagnostic imaging centers
- Cancer research institutes
- Others
On the basis of end user, the Europe throat cancer diagnostics market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others.
Distribution Channel
- Direct tender
- Retail sales
On the basis of distribution channel, the Europe throat cancer diagnostics market is segmented into direct tender and retail sales.
Europe Throat Cancer Diagnostics Market Regional Analysis/Insights
The Europe throat cancer diagnostics market is analysed, and market size insights and trends are provided by country, product type, test type, cancer type, stages, age group, end user, and distribution channel, as referenced above.
The countries covered in this market report are Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, the rest of Europe.
Germany is expected to dominate the Europe throat cancer diagnostics market due to the rising incidence and prevalence of throat nodules and cancer.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Europe brands and their challenges faced due to competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Throat Cancer Diagnostics Market Share Analysis
The Europe throat cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to Europe throat cancer diagnostics market.
Some of the major players operating in the Europe throat cancer diagnostics market are F. Hoffmann-La Roche Ltd., Abbott., Illumina, QIAGEN, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Inc. Merck KGaA., Hologic, Inc., General Electric Company, Siemens Healthcare GmbH, B.D, Myriad Genetics, Inc., Diasorin S.P.A, Koninklijke Philips N.V., Beijing O&D Biotech Co., Ltd, PlexBio Co, Ltd., FUJIFILM Corporation, Canon Inc., FONAR Corp., Medonica Co. LTD, MinFound Medical Systems Co, Sternmed Gmbh, Time Medical Holding., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE THROAT CANCER DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 INDUSTRY INSIGHTS
6 EPIDEMIOLOGY
7 EUROPE THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS
7.1 REGULATORY SCENARIO IN THE U.S
7.2 REGULATORY SCENARIO IN AUSTRALIA
7.3 REGULATORY SCENARIO IN JAPAN
7.4 REGULATORY SCENARIO IN CHINA
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 GROWING PREVALENCE OF THROAT CANCER
8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS
8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER
8.2 RESTRAINTS
8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER
8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES.
8.3 OPPORTUNITIES
8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT
8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS
8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.4 CHALLENGES
8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES
8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
9 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 INSTRUMENTS
9.2.1 PATHOLOGY-BASED INSTRUMENTS
9.2.1.1 PCR INSTRUMENTS
9.2.1.2 SLIDE STAINING SYSTEMS
9.2.1.3 TISSUE PROCESSING SYSTEMS
9.2.1.4 CELL PROCESSORS
9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS
9.2.2 IMAGING INSTRUMENTS
9.2.2.1 ULTRASOUND SYSTEMS
9.2.2.2 CT SYSTEMS
9.2.2.3 MRI SYSTEMS
9.2.2.4 OTHERS
9.2.3 BIOPSY INSTRUMENTS
9.2.4 OTHERS
9.3 CONSUMABLES & ACCESSORIES
9.3.1 KITS
9.3.1.1 PCR KITS
9.3.1.2 DNA POLYMERASE KITS
9.3.1.3 NUCLEIC ACID ISOLATION KITS
9.3.1.4 OTHERS
9.3.2 REAGENTS
9.3.2.1 ASSAYS
9.3.2.2 BUFFERS
9.3.2.3 PRIMERS
9.3.2.4 OTHERS
9.3.3 PROBES
9.3.4 OTHER CONSUMABLES
10 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE
10.1 OVERVIEW
10.2 IMAGING TEST
10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN
10.2.2 MRI
10.2.3 CHEST X-RAY
10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN
10.2.5 OTHERS
10.3 BLOOD TEST
10.3.1 BLOOD CHEMISTRY TESTS
10.3.2 COMPLETE BLOOD COUNT (CBC)
10.3.3 OTHERS
10.4 BIOPSY
10.4.1 ENDOSCOPIC BIOPSY
10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY
10.4.3 OTHERS
10.5 OTHERS
11 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
11.1 OVERVIEW
11.2 PHARYNGEAL CANCER
11.2.1 NASOPHARYNGEAL CANCER
11.2.2 OROPHARYNGEAL CANCER
11.2.3 HYPOPHARYNGEAL CANCER
11.3 LARYNGEAL CANCER
12 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES
12.1 OVERVIEW
12.2 STAGE III
12.3 STAGE II
12.4 STAGE IV
12.5 STAGE I
12.6 STAGE 0
13 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY AGE
13.1 OVERVIEW
13.2 30-65
13.3 65 AND ABOVE
13.4 21-29
13.5 BELOW 21
14 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 ASSOCIATED LABS
14.4 INDEPENDENT DIAGNOSTIC LABORATORIES
14.5 DIAGNOSTIC IMAGING CENTERS
14.6 CANCER RESEARCH INSTITUTES
14.7 OTHERS
15 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 RETAIL SALES
16 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY REGION
16.1 EUROPE
16.1.1 GERMANY
16.1.2 FRANCE
16.1.3 U.K.
16.1.4 ITALY
16.1.5 SPAIN
16.1.6 RUSSIA
16.1.7 TURKEY
16.1.8 NETHERLANDS
16.1.9 BELGIUM
16.1.10 SWITZERLAND
16.1.11 REST OF EUROPE
17 EUROPE THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: EUROPE
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 F. HOFFMANN- LA ROCHE LTD
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENT
19.2 FUJIFILM CORPORATION
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENT
19.3 THERMO FISHER SCIENTIFIC INC.
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 CANON MEDICAL SYSTEMS CORPORATION
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENT
19.5 KONINKLIJKE PHILIPS N.V.
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENT
19.6 ABBOTT
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 AGILENT TECHNOLOGIES, INC.
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENT
19.8 BD
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENTS
19.9 BEIJING O&D BIOTECH CO., LTD.
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENT
19.1 BIO-RAD LABORATORIES, INC.
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 FONAR CORP.
19.11.1 COMPANY SNAPSHOT
19.11.2 REVENUE ANALYSIS
19.11.3 PRODUCT PORTFOLIO
19.11.4 RECENT DEVELOPMENT
19.12 GE HEALTHCARE
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENT
19.13 HOLOGIC INC.
19.13.1 COMPANY SNAPSHOT
19.13.2 REVENUE ANALYSIS
19.13.3 PRODUCT PORTFOLIO
19.13.4 RECENT DEVELOPMENT
19.14 ILLUMINA, INC.
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT DEVELOPMENT
19.15 MEDONICA CO. LTD
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 MERCK KGAA
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 MINFOUND MEDICAL SYSTEMS CO., LTD
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 MYRIAD GENETICS, INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 REVENUE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENT
19.19 PLEXBIO
19.19.1 COMPANY SNAPSHOT
19.19.2 PRODUCT PORTFOLIO
19.19.3 RECENT DEVELOPMENT
19.2 QIAGEN
19.20.1 COMPANY SNAPSHOT
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENT
19.21 QUEST DIAGNOSTICS INCORPORATED
19.21.1 COMPANY SNAPSHOT
19.21.2 REVENUE ANALYSIS
19.21.3 PRODUCT PORTFOLIO
19.21.4 RECENT DEVELOPMENT
19.22 SIEMENS HEALTHCARE GMBH
19.22.1 COMPANY SNAPSHOT
19.22.2 REVENUE ANALYSIS
19.22.3 PRODUCT PORTFOLIO
19.22.4 RECENT DEVELOPMENT
19.23 STERNMED GMBH
19.23.1 COMPANY SNAPSHOT
19.23.2 PRODUCT PORTFOLIO
19.23.3 RECENT DEVELOPMENT
19.24 TIME MEDICAL HOLDING.
19.24.1 COMPANY SNAPSHOT
19.24.2 PRODUCT PORTFOLIO
19.24.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
List of Table
TABLE 1 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 EUROPE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 EUROPE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 EUROPE CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 13 EUROPE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 15 EUROPE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 17 EUROPE OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 19 EUROPE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 EUROPE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 21 EUROPE LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 23 EUROPE STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 EUROPE STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 EUROPE STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 29 EUROPE 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 EUROPE BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 EUROPE HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 EUROPE ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION)
TABLE 36 EUROPE INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 EUROPE DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 EUROPE CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 EUROPE OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 EUROPE DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 EUROPE RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 44 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 EUROPE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 46 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 EUROPE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 EUROPE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 EUROPE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 EUROPE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 51 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 52 EUROPE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 53 EUROPE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 54 EUROPE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 55 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 56 EUROPE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 57 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 58 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 59 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 60 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 61 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 GERMANY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 GERMANY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 GERMANY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 GERMANY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 66 GERMANY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 GERMANY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 69 GERMANY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 70 GERMANY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 71 GERMANY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 72 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 73 GERMANY PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 74 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 75 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 76 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 77 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 78 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 FRANCE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 FRANCE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 FRANCE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 FRANCE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 FRANCE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 FRANCE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 86 FRANCE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 87 FRANCE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 88 FRANCE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 89 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 90 FRANCE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 91 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 92 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 93 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 94 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 95 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 U.K. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 U.K. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.K. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 U.K. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.K. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.K. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 103 U.K. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.K. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 105 U.K. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 106 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 107 U.K. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 109 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 110 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 112 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 ITALY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 114 ITALY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 ITALY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 ITALY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 ITALY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 ITALY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 120 ITALY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 121 ITALY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 122 ITALY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 123 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 124 ITALY PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 125 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 126 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 127 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 128 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 129 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 SPAIN INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 SPAIN PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 SPAIN IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 SPAIN CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 134 SPAIN KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 SPAIN REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 137 SPAIN IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 138 SPAIN BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 139 SPAIN BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 140 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 141 SPAIN PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 142 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 143 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 144 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 145 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 146 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 147 RUSSIA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 RUSSIA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 RUSSIA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 RUSSIA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 RUSSIA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 RUSSIA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 154 RUSSIA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 155 RUSSIA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 156 RUSSIA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 157 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 158 RUSSIA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 159 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 160 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 161 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 162 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 163 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 TURKEY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 TURKEY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 TURKEY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 TURKEY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 168 TURKEY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 169 TURKEY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 171 TURKEY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 172 TURKEY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 173 TURKEY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 174 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 175 TURKEY PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 176 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 177 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 178 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 179 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 180 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 NETHERLANDS INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 NETHERLANDS PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 NETHERLANDS CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 NETHERLANDS KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 NETHERLANDS REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 186 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 187 NETHERLANDS IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 188 NETHERLANDS BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 189 NETHERLANDS BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 190 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 191 NETHERLANDS PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 192 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 193 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 194 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 195 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 196 BELGIUM THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 BELGIUM INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 BELGIUM PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 BELGIUM IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 BELGIUM CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 BELGIUM KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 BELGIUM REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 203 BELGIUM THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 204 BELGIUM IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 205 BELGIUM BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 206 BELGIUM BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 207 BELGIUM THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 208 BELGIUM PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 209 BELGIUM THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 210 BELGIUM THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 211 BELGIUM THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 212 BELGIUM THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 213 SWITZERLAND THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 SWITZERLAND INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 SWITZERLAND PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 216 SWITZERLAND IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 SWITZERLAND CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 SWITZERLAND KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 219 SWITZERLAND REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 SWITZERLAND THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 221 SWITZERLAND IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 222 SWITZERLAND BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 223 SWITZERLAND BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 224 SWITZERLAND THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 225 SWITZERLAND PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 226 SWITZERLAND THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 227 SWITZERLAND THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 228 SWITZERLAND THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 SWITZERLAND THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 230 REST OF EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 EUROPE THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 EUROPE THROAT CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE THROAT CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE THROAT CANCER DIAGNOSTICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE THROAT CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE THROAT CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE THROAT CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE THROAT CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE THROAT CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THROAT CANCER IS EXPECTED TO DRIVE THE EUROPE THROAT CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE INSTRUMENT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE THROAT CANCER DIAGNOSTICS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE THROAT CANCER DIAGNOSTICS MARKET
FIGURE 14 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022
FIGURE 19 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 22 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022
FIGURE 23 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030)
FIGURE 25 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE
FIGURE 26 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2022
FIGURE 27 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030)
FIGURE 29 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE
FIGURE 30 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022
FIGURE 31 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030)
FIGURE 33 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 34 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2022
FIGURE 35 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 36 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 39 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 40 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 41 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 EUROPE THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 43 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 44 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 46 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 47 EUROPE THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
